Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • January–March 2024
Letter to the Editor: The Catastrophic Perception of Pain in Burning Mouth Syndrome May be Associated with Sympathetic Tone as Indicated by the QTc Interval

By |March 1, 2024|Comments Off on Letter to the Editor: The Catastrophic Perception of Pain in Burning Mouth Syndrome May be Associated with Sympathetic Tone as Indicated by the QTc Interval

Innov Clin Neurosci. 2024;21(1–3):8–9. Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: Unexplained somatic symptoms [...]

Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials

By |March 1, 2024|Comments Off on Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials

by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD  Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown University Medical School in Washington, [...]

Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward

By |March 1, 2024|Comments Off on Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward

by William P. Horan, PhD; Gary Sachs, MD; Dawn I. Velligan, PhD; Michael Davis, MD, PhD; Richard S.E. Keefe, PhD; Ni A. Khin, MD; Florence Butlen-Ducuing, MD, PhD; and Philip D. Harvey, PhD Dr. Horan [...]

Health Anxiety, Fear of COVID-19, Nosophobia, and Health-protective Behaviors Among Healthcare Professionals

By |March 1, 2024|Comments Off on Health Anxiety, Fear of COVID-19, Nosophobia, and Health-protective Behaviors Among Healthcare Professionals

by Uzma Ilyas, PhD scholar; Farwa Aslam, MS; Muqadas Fatima, MS; Zarmin Tariq, MS; and Prof Dr. Usman Hotiana, MBBS, FCPS (Psychology) Ms. Ilyas is Principal Lecturer, Psychology Department, University of Central Punjab in Lahore, [...]

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

By |March 1, 2024|Comments Off on Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

by Mark G. A. Opler, PhD, MPH; Amy Claxton, PhD*; James McGrory, PhD; Sabina Gasper, MPH*; Meihua Wang, PhD*; and Sergey Yagoda, MD, PhD  Dr. Opler is with WCG, Inc. in New York, New York. [...]

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group

By |March 1, 2024|Comments Off on Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group

by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf, MD; Joan Fallon, BS, DC; Larry D. Alphs, MD, PhD; Maria T. Acosta, MD; Anna-Karin Berger, PhD; Simon Day, PhD; Judith Dunn, PhD; Victoria Villalta-Gil, [...]

Past Articles